GO will be presenting a poster on our novel glycoprotein tumor targeting ADCs at #AACR24. We hope that these next generation ADCs will pave the way for more efficacious and less toxic cancer therapies.
GO Therapeutics的动态
最相关的动态
-
I wanted to share some exciting news from CPI, as our latest research has achieved a significant breakthrough in cancer treatment. The research has shown that drug-loaded 3D-printed films can potentially revolutionize cancer treatments. The new films have proven to be effective in killing over 80% of liver cancer cells, and they could also significantly reduce recurrence rates. Moreover, the new treatment could minimize the systematic toxicities of traditional chemotherapy. This world-first research is a significant development in the fight against cancer. https://lnkd.in/gv-G726z
Targeted liver cancer treatment kills cancer cells and cuts chemo side effects
https://www.youtube.com/
-
ArteraAI's MMAI biomarker has been rigorously validated for #prognostic and predictive performance in patients with #prostatecancer across the disease spectrum. As the first test to provide actionable results for short-term ADT and prognosticate long-term outcomes in localized prostate cancer, the ArteraAI #Prostate Test was validated using data from multiple Phase 3 randomized trials with up to 15-years follow-up. With AI models developed using clinical trial data comprising approximately 20% African American men (a historically underrepresented group in clinical trials), our clinically available, laboratory-developed test can support personalized treatment decision-making with more accurate representation. Cancer is personal. Cancer therapy should be, too. ?? Learn more at artera.ai
-
Check out this insightful article in Happiest Health by Dr. Chandandeep Kaur on the role of aged immune cells in cancer and the potential of clearing them out for effective cancer treatment. The summary is derived from paper published in Cancer Cell (https://lnkd.in/dCETXJam) showing how clearance of senescent macrophages ameliorates tumorigenesis in KRAS-derived lung cancer! https://lnkd.in/dUGXbZ7S
-
-
McKinsey, lives and livelihoods communications, leading growth and operational excellence, Board and C-suite executive
AI applied in cancer drug development - hear from our colleagues in this 38-second video or its longer version in the linked article. Cancer is fast. Developing a new cancer medicine is not. Learn how McKinsey & Company is helping clients accelerate discovery and development of new cancer treatments through the application of AI. ? https://lnkd.in/dMrFnhwV #RewritingCancer #McKinseyDigital #AIbyMcKinsey
-
Five key factors predict the response of cancer patients to immunotherapy Researchers from VHIO are participating in an international study led by IRB Barcelona that identifies five independent factors predicting cancer patients’ responses to immune checkpoint inhibitors (CPIs). Published in?"Nature Genetics", the study validates these factors in more than 1,400 patients and various cancer types. These findings provide a framework to interpret biomarkers of response to CPIs and suggest a future pathway to improve personalised cancer medicine. #PrecisionMedicine #immunotherapy https://lnkd.in/d5mSAmZE
-
The month of March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the second leading cause of cancer death in the US. Learn how the team here at Panome Bio used integrated #multiomics analysis of #transcriptomic, #proteomic and #metabolomic data to reveal novel insights into mechanistic changes in colorectal cancer. https://hubs.ly/Q02mSgFd0
-
-
Forget cat-and-mouse! In the fight against prostate cancer, PSMA-Targeted Therapy is the new sheriff in town. This innovative approach takes aim at a protein called PSMA, found in abundance on prostate cancer cells. Think of it as a homing missile, delivering radiation directly to the bad guys while leaving healthy tissues unharmed. Stay tuned for more updates on this exciting technology and its impact on prostate cancer patients. #PSMAtherapy #PrecisionMedicine #CancerTreatment #GameChanger #PSMAimaging #HopeForCancer #TargetedTherapy #MedicalInnovation #CancerAwareness #AdvancedTreatment #PSMArevolution #HealthcareAdvances #TumorTargeting?
-
Attended Cancer Crosslinks 2024 today?? #OsloCancerCluster, Bridging innovations to improve clinical outcomes for cancer patients. Wonderful presentations on :?EXPLORING THE FUTURE OF CANCER IMMUNOTHERAPY,?IMPACTS ON CLINICAL OUTCOMES BY TARGETING TUMOR HETEROGENEITY and?EMERGING PLATFORMS FOR CANCER TREATMENT DELIVERY.? #immunotherapy, #antibodydrugconjugates, #immuneoncology, #aiinmedicine ?
-
-
Unlocking Potential Synergy in Cancer Treatments: Simplified ? Previous review posts covered the modalities ?? Imagine how this trident approach might boost cancer care effectiveness: 1. cell therapy 2. checkpoint inhibitors 3. oncolytic viruses #Immunotherapy #PrecisionMedicine #Oncology #CancerResearch #OncologyEducation
-
A cancer diagnosis can be overwhelming, making it difficult to navigate treatment with confidence. The #ArteraAI Prostate Test can help mitigate uncertainty around treatment choices. As the first-ever predictive test for localized #prostatecancer, the ArteraAI #ProstateTest can estimate how an individual’s cancer might progress and predict how well a therapy might work, providing personalized results for shared decision-making. ?? Cancer is personal. Cancer therapy should be, too. Learn more at artera.ai.
